Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2017-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2017.12.023PMID 29426628PMCID PMC5895456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Frontiers in Physiology

  2020cited by this paper
• Advances in Hepatology

  2019cited by this paper
• Protective effects of 6-ureido/thioureido-2,4,5-trimethylpyridin-3-ols against 4-hydroxynonenal-induced cell death in adult retinal pigment epithelial-19 cells.

  2018cited by this paper
• Guidelines in cardiovascular research, a first for the American Journal of Physiology-Heart and Circulatory Physiology.

  2017cited by this paper
• DioxolaneA3-phosphatidylethanolamines are generated by human platelets and stimulate neutrophil integrin expression

  2017cited by this paper
• Substrate and inhibitor specificity of kynurenine monooxygenase from Cytophaga hutchinsonii.

  2017cited by this paper
• Extracellular Cysteine in Connexins: Role as Redox Sensors

  2016cited by this paper
• Wound Healing Problems in the Mouth

  2016cited by this paper
• The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts

  2016cited by this paper
• Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation

  2015cited by this paper
• Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques

  2014cited by this paper
• NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses

  2014cited by this paper
• High-throughput Assays for Superoxide and Hydrogen Peroxide

  2014cited by this paper
• Nox4: A Hydrogen Peroxide-Generating Oxygen Sensor

  2014cited by this paper
• NADPH Oxidase 4 Is Expressed in Pulmonary Artery Adventitia and Contributes to Hypertensive Vascular Remodeling

  2014cited by this paper
• NADPH Oxidases in Chronic Liver Diseases.

  2014cited by this paper
• Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.

  2014cited by this paper
• Nox‐4 deletion reduces oxidative stress and injury by PKC‐α‐associated mechanisms in diabetic nephropathy

  2014cited by this paper
• NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.

  2013cited by this paper
• Increased Oxidative Stress in the Nucleus Caused by Nox4 Mediates Oxidation of HDAC4 and Cardiac Hypertrophy

  2013cited by this paper
• Role of nicotinamide adenine dinucleotide phosphate-reduced oxidase proteins in Pseudomonas aeruginosa-induced lung inflammation and permeability.

  2013cited by this paper
• Antioxidants ＆ redox signaling

  2013cited by this paper
• On the use of L-012, a luminol-based chemiluminescent probe, for detecting superoxide and identifying inhibitors of NADPH oxidase: a reevaluation.

  2013cited by this paper
• Polymerase Delta Interacting Protein 2 Sustains Vascular Structure and Function

  2013cited by this paper
• Characterisation of Nox4 Inhibitors from Edible Plants

  2013cited by this paper
• From form to function: the role of Nox4 in the cardiovascular system

  2012cited by this paper
• Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase

  2012cited by this paper
• NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS

  2012cited by this paper
• PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuate aldosterone/NaCl-induced hypertension in mice.

  2012cited by this paper
• The NADPH Oxidase Family and its Inhibitors

  2012cited by this paper
• PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes.

  2012cited by this paper
• NADPH oxidase inhibitors: a patent review

  2011cited by this paper
• Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets

  2011cited by this paper
• NADPH Oxidase 4 Promotes Endothelial Angiogenesis Through Endothelial Nitric Oxide Synthase Activation

  2011cited by this paper
• The impact of ionization States of matrix metalloproteinase inhibitors on docking-based inhibitor design.

  2011cited by this paper
• NADPH Oxidase Subunit 4-Mediated Reactive Oxygen Species Contribute to Cycling Hypoxia-Promoted Tumor Progression in Glioblastoma Multiforme

  2011cited by this paper
• Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors.

  2011cited by this paper
• Endothelial Nox4 NADPH Oxidase Enhances Vasodilatation and Reduces Blood Pressure In Vivo

  2011cited by this paper
• NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor.

  2011cited by this paper
• PHARMACOPHORE PERCEPTION , DEVELOPMENT , AND USE IN DRUG DESIGN

  2011cited by this paper
• Inhibition of Reactive Oxygen Species by Lovastatin Downregulates Vascular Endothelial Growth Factor Expression and Ameliorates Blood-Retinal Barrier Breakdown in db/db Mice

  2010cited by this paper
• Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration

  2010cited by this paper
• First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.

  2010cited by this paper
• Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxia

  2010cited by this paper
• Small-molecule inhibitors of NADPH oxidase 4.

  2010cited by this paper
• NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart

  2010cited by this paper
• Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.

  2010cited by this paper
• Inhibition of reactive oxygen species by lovastatin down-regulates VEGF expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4

  2010cited by this paper
• NADPH Oxidase-4 Mediates Myofibroblast Activation and Fibrogenic Responses to Lung Injury

  2009cited by this paper
• Pyrazolopyridine derivatives as nadph-oxidase inhibitors

  2009cited by this paper
• Mechanisms of Vascular Smooth Muscle NADPH Oxidase 1 (Nox1) Contribution to Injury-Induced Neointimal Formation

  2009cited by this paper
• Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice.

  2009cited by this paper
• Small-Molecule NOX Inhibitors: ROS-Generating NADPH Oxidases as Therapeutic Targets

  2009cited by this paper
• Effects of angiotensin receptor blocker on oxidative stress and cardio-renal function in streptozotocin-induced diabetic rats.

  2009cited by this paper
• NADPH oxidases in lung biology and pathology: host defense enzymes, and more.

  2008cited by this paper
• NADPH oxidases in lung biology and pathology: host defense enzymes, and more.

  2008cited by this paper
• The NOX on pulmonary hypertension.

  2007cited by this paper
• Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary Vasculature

  2007cited by this paper
• Nox4 Is Required for Maintenance of the Differentiated Vascular Smooth Muscle Cell Phenotype

  2007cited by this paper
• Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells.

  2006cited by this paper
• Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.

  2006cited by this paper
• PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results

  2006cited by this paper
• Nox4 NAD(P)H Oxidase Mediates Hypertrophy and Fibronectin Expression in the Diabetic Kidney*

  2005cited by this paper
• Increased NADPH-Oxidase Activity and Nox4 Expression During Chronic Hypertension Is Associated With Enhanced Cerebral Vasodilatation to NADPH In Vivo

  2004cited by this paper
• Increased myocardial NADPH oxidase activity in human heart failure.

  2003cited by this paper
• Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis

  2002cited by this paper
• A Novel Superoxide-producing NAD(P)H Oxidase in Kidney*

  2001cited by this paper
• Rapid microplate assay for superoxide scavenging efficiency.

  2000cited by this paper
• Identification of renox, an NAD(P)H oxidase in kidney.

  2000cited by this paper
• Lucigenin (bis-N-methylacridinium) as a mediator of superoxide anion production.

  1997cited by this paper
• Cardiovascular Research

  1966cited by this paper

• NOX4-Mediated Oxidative Stress in Diabetic Complications: Potential of Natural Products

  2026cites this paper
• Natural Compounds as Nephroprotective Agents: Therapeutic Potential Against Drug‐Induced Kidney Injury

  2025cites this paper
• Advances in the pharmacological study of Chinese herbal medicine to alleviate diabetic nephropathy by improving mitochondrial oxidative stress.

  2023cites this paper
• NADPH oxidases in GtoPdb v.2023.3

  2023cites this paper
• Cyclophilin D-mediated angiotensin II-induced NADPH oxidase 4 activation in endothelial mitochondrial dysfunction that can be rescued by gallic acid.

  2022cites this paper
• Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation.

  2022cites this paper
• Dietary salt initiates redox signaling between endothelium and vascular smooth muscle through NADPH oxidase 4

  2022cites this paper
• Synthesis of some novel piperidine fused 5-thioxo-1H-1,2,4-triazoles as potential antimicrobial and antitubercular agents

  2021cites this paper
• Biomimetic synthesis and anti-inflammatory evaluation of violacin A analogues.

  2021cites this paper
• Ag-Catalyzed Multicomponent Synthesis of Heterocyclic Compounds: A Review.

  2021cites this paper
• Design, synthesis, and screening of sulfonylurea-derived NLRP3 inflammasome inhibitors

  2019cites this paper
• The NADPH Oxidase Family and Its Inhibitors

  2019cites this paper
• NADPH oxidases (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Novel Aminomethyl Derivatives of 4‐Methyl‐2‐prenylphenol: Synthesis and Antioxidant Properties

  2019cites this paper
• Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs).

  2019cites this paper
• In-silico design, synthesis, ADMET studies and biological evaluation of novel derivatives of Chlorogenic acid against Urease protein and H. Pylori bacterium

  2019cites this paper
• Seven-membered N-heterocycles: metal and nonmetal assisted synthesis

  2019cites this paper
• Gold and silver assisted synthesis of five-membered oxygen and nitrogen containing heterocycles

  2019cites this paper
• Lead optimization for promising monoamine oxidase inhibitor from eugenol for the treatment of neurological disorder: synthesis and in silico based study

  2019cites this paper
• Separation of ephedrine and pseudoephedrine enantiomers using a polysaccharide-based chiral column: A normal phase liquid chromatography-high-resolution mass spectrometry approach.

  2019cites this paper
• Biological Impacts of Metal(II) Complex–Based DNA Probes Derived from Bidentate N,O Donor Schiff Base Ligand

  2019cites this paper
• Synthesis of five-membered N-heterocycles using silver metal

  2019cites this paper
• Potential benefits and harms of NADPH oxidase type 4 in the kidneys and cardiovascular system.

  2018cites this paper
• Stereoselective Synthesis of (3S, 4R)-5-Phenylpentane-1, 3, 4-Triol

  2018cites this paper
• Synthesis of Novel Pyrido[2′, 3′:3,4]Pyrazolo[1, 5‐ a ]Quinazoline Derivatives, Their Biological Evaluation and Molecular Modelling Studies

  2018cites this paper
• Hybrid caffeic acid derivatives as monoamine oxidases inhibitors: synthesis, radical scavenging activity, molecular docking studies and in silico ADMET analysis

  2018cites this paper